Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on June 25, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Board expanded from 9 to 10 directors through Carolyn S. Starrett’s immediate appointment.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from 9 to 10 directors through Carolyn S. Starrett’s immediate appointment
- Starrett classified as an independent director under the company’s existing compensation program
- Appointment runs through the 2027 annual meeting, subject to earlier resignation or removal
Item 7.01 · Regulation FD Disclosure
- Board appointment press release for Ms. Starrett issued June 25, 2026
- Exhibit 99.1 contains appointment details and potential governance implications
- Reg FD disclosure not deemed filed under Exchange Act Section 18
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.